Table 4. Prognostic values (p value and Hazard Ratios when p-value < 0.05) of classical prognostic factors derived from initial staging and of metrics derived from initial FDG-PET, on univariate analysis.
EWS | OST | |||||||
---|---|---|---|---|---|---|---|---|
Parameter | PFS | OS | PFS | OS | ||||
p-value | Hazard Ratio | p-value | Hazard Ratio | p-value | Hazard Ratio | p-value | Hazard Ratio | |
Bone Metastasis | 0.0008 | 11.466 | 0.053 | 6.074 | ||||
Lung Metastasis | 0.0143 | 5.941 | 0.619 | - | 0.003 | 6.427 | 0.01 | 6.26 |
Histologicsubtypes | - | - | - | - | 0.018 | 0.265 | 0.04 | 0.247 |
Elongation | 0.0044 | 5.684 | 0.0062 | 7.113 |
Significant p-value in bold.
For EWS, anatomic primary site corresponds to primary tumor site (axial/pelvic vs peripheral).
For OST, histologic subtypes compares Osteoblastic vs Chondroblastic/Telangiectatic subtypes.
EWS: Ewing sarcoma; OST: Osteosarcoma